First Time Loading...

Augmedix Inc

Watchlist Manager
Augmedix Inc Logo
Augmedix Inc
Price: 5.15 USD +3.62% Market Closed
Updated: Sep 30, 2023

Intrinsic Value

Intrinsic Value History
Augmedix Inc

Whether you're assessing long-term stability or short-term opportunities, Historical Valuation serves as a vital tool to enhance your investment approach, enabling you to make more informed investment decisions.

This feature available only with
Unlimited Plan

Sign up to access Augmedix Inc's intrinsic value history.

No restrictions, no limits.
All stocks, all tools.

Spot Contrarian Opportunities

Look for stocks that have been historically overvalued but are now trading below their intrinsic value.

Easily Identify Value Traps

Avoid stocks that are always undervalued and never reach their intrinsic value.

Find Strong Rebounds

Find stocks that have historically corrected quickly from being undervalued to reaching their intrinsic value.

Valuation Methods

There are two methods to calculate the Intrinsic Value of a stock: DCF Valuation and Relative Valuation. We take the average of these two methods to estimate the intrinsic value as accurately as possible. You can see the Intrinsic Value of a stock at the top of this page.

DCF Value
Discounted Cash Flow

DCF Parameters:
Operating Model
Discount Rate
Forecast Period
Terminal Growth
DCF Input
DCF Input
DCF Input

Fundamental Analysis


Balance Sheet Decomposition
Augmedix Inc

Current Assets 36.1m
Cash & Short-Term Investments 24.6m
Receivables 9.4m
Other Current Assets 2.1m
Non-Current Assets 7.8m
PP&E 6.2m
Other Non-Current Assets 1.5m
Current Liabilities 21.3m
Accounts Payable 1.6m
Accrued Liabilities 6m
Other Current Liabilities 13.7m
Non-Current Liabilities 18.6m
Long-Term Debt 14.9m
Other Non-Current Liabilities 3.7m
Fundamental Scores

AUGX Profitability Score
Profitability Due Diligence

Augmedix Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROIC is Increasing

Augmedix Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

AUGX Solvency Score
Solvency Due Diligence

Augmedix Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Long-Term Solvency
High D/E

Augmedix Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AUGX Price Targets Summary
Augmedix Inc

Wall Street analysts forecast AUGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUGX is 6.76 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

Price Target
6.06 USD
18% Upside
Price Target
6.76 USD
31% Upside
Price Target
8.4 USD
63% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape


AUGX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

AUGX Return Decomposition
Main factors of price return

What is price return decomposition?

AUGX Price
Augmedix Inc

1M 1M
6M 6M
1Y 1Y
3Y 3Y
5Y 5Y
10Y 10Y
Annual Price Range
52w Low
52w High
Price Metrics
Average Annual Return -35.2%
Standard Deviation of Annual Returns
Max Drawdown -86%
Shares Statistics
Market Capitalization 210m USD
Shares Outstanding 40 675 500
Percentage of Shares Shorted 1.35%

Company Profile

Augmedix Inc Logo
Augmedix Inc


United States of America


Health Care

Market Cap

210m USD

Dividend Yield



Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 706 full-time employees. The company went IPO on 2021-03-04. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and provides a suite of related services. The medical note is generated using Augmedix’s proprietary platform, which incorporates structured data models, automatic speech recognition and natural language processing and is overseen by trained medical documentation specialists (MDS). Augmedix provides service from approximately nine MDS operations centers across four countries: the United States, Bangladesh, India and Sri Lanka.


San Francisco
111 Sutter Street, Suite 1300, Suite Ll






Pres, CEO, Sec. & Director
Mr. Emmanuel Krakaris
Founder, Chief Strategy Officer & Director
Mr. Ian Shakil
Chief Operating Officer
Ms. Sandra Breber
Chief Technology Officer
Mr. Saurav Chatterjee Ph.D.
Chief Financial Officer
Mr. Paul Louis Ginocchio
Head of Legal & Compliance
Todd Holvick
Show More
Head of People
Lia Wallick
Chief Medical Officer
Dr. Davin Lundquist M.D.
Chief Revenue Officer
Mr. Jonathan Hawkins
Show Less

See Also

Other Stocks
What is the Intrinsic Value of one AUGX stock?

The intrinsic value of one AUGX stock under the Base Case scenario is 2.25 USD.

Is AUGX stock undervalued or overvalued?

Compared to the current market price of 5.15 USD, Augmedix Inc is Overvalued by 56%.